Delivery Order SPE2DB20D9127-SPE2DB25FPPU0

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,239.04 contract provides for the delivery of 4,567,192,930 units of the pharmaceutical product FLUCYTOSINE 500 MG CAPSULE UD 30S. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract worth $5,221.64 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of fluconazole tablets, with a completion date of December 29, 2023. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract #4600082013 with the Defense Logistics Agency, valued at up to $4,999,999...
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) for the supply of fluconazole tablets. The contract has a ceiling value of $1,120.44 and a period of performance ending on August 9, 2024. It is a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies...
This federal contract award is for a delivery order (SPE2DX24FKWJR) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $14,087.25 and is a firm fixed-price delivery order with no set-aside designation. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up...
This firm fixed-price delivery order contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,112.16, is for the delivery of fluconazole tablets to support the recurring medical supply needs of DoD healthcare facilities worldwide. DMS Pharmaceutical Group Inc....
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract worth $5,252.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of fluconazole tablets and has a completion date of December 29, 2023. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with the Defense Logistics Agency valued up to $4,999,999 through 2025, which enables the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $18,526.83 and an ultimate completion date of August 7, 2024. This award is under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,263.16 contract is for the supply of 4560827135 - FLUORESCITE 10% VIAL 5ML, with a performance period ending on April 17, 2023. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, known as SPE2DB, covers a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The specific award, valued at $1,626.26, is for the supply of fluticasone propionat to the DLA's...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $1,413.24 for the supply of pharmaceutical products, including medications such as fluticasone propionate. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which supports the recurring medical supply needs of military health facilities and VA medical centers nationwide. The contract is a firm...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPPU0
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a total ceiling value of $12,298.05 and covers the delivery of Flucytosine 500 mg capsules with a completion date of February 4, 2025.

DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the issuance of firm fixed-price delivery orders for a wide variety of pharmaceutical items.

This contract award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/5/25, 9:52 AM